- COMPOUNDS FOR THE TREATMENT AND PREVENTION OF INFLUENZA
-
A compound of formula (I) as well as pharmaceutically acceptable salt thereof, wherein R1 to R4 and Ar are as defined in description and in claims, can be used as a medicament.
- -
-
-
- COMPOUNDS FOR THE TREATMENT AND PREVENTION OF INFLUENZA
-
A compound of formula (I) as well as pharmaceutically acceptable salt thereof, wherein R1 to R4 and Ar are as defined in description and in claims, can be used as a medicament.
- -
-
-
- COMPOUNDS FOR THE TREATMENT AND PREVENTION OF INFLUENZA
-
A compound of formula (I) as well as pharmaceutically acceptable salt thereof, wherein R1 to R4 and Ar are as defined in description and in claims, can be used as a medicament.
- -
-
-
- Synthesis of 3H-labeled 2-hydroxy-N-[(1,3,3-trimethyl-[4,5,6-3H]cyclohexyl)methyl]-5-azidobenzamide, a photoaffinity analog of an influenza fusion inhibitor
-
Synthesis of 3H-labeled 2-hydroxy-N-[(1,3,3-trimethyl-[4,5,6-3H]cyclohexyl)methyli]-5-azidobenzamide, a photoaffinity analog of an influenza fusion inhibitor, is reported. Tritiation of a mixture of N-(t-butoxycarbonyl)-1,3,3-trimethylcyclohex-4 (or 5)-enylmethylamine via T2 and Pd/C, followed by coupling of the deprotected tritiated amine with acetyl 5-azidosalicylic acid chloride yielded the penultimate product. Subsequent deprotection and normal phase HPLC purification yielded the target compound with a radiochemical purity > 99% and a specific activity of 63 Ci/mmol.
- Dischino, Douglas D.,Cianci, Christopher,Krystal, Mark,Meanwell, Nicholas A.,Morimoto, Hiromi,Pearce, Bradley C.,Williams, Philip,Yu, Kuo-Long
-
p. 965 - 974
(2007/10/03)
-